StockProfiler.US: Alternative Energy & Pharmaceutical Companies Second Quarter Financial Results

Posted on: Thu, 29 Jul 2010 13:17:06 EDT

Symbols: AEGC, GPRE

Boston, MA, Jul 29, 2010 (M2 PRESSWIRE via COMTEX) --

Green Plains Renewable Energy, Inc. (NASDAQ: GPRE | PowerRating); Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX)

Stock Profiler welcomes investors to sign up at www.stockprofiler.us to subscribe to our FREE Investor Tools, Newsletter, and Market Updates.

NOTE: All news contained herein has been previously issued by the companies mentioned in this release, and is the property of each company, respectively. All news is edited for content. To read the news in its entirety, go to the Leader in Market News, Stock Profiler.US, LLC (www.stockprofiler.us) click the Headline Tab, enter the ticker symbol and click the news link.

-------------------------------------------

Green Plains Renewable Energy, Inc. closed at $10.00 Wednesday, trading 146,600 shares.

Green Plains Renewable Energy, Inc. Reports Second Quarter 2010 Financial Results

OMAHA, Neb., July 28, 2010 -- Green Plains Renewable Energy, Inc. (NASDAQ: GPRE) announced today its financial results for the second quarter of 2010.

About Green Plains Renewable Energy, Inc.

Green Plains Renewable Energy, Inc. (Nasdaq:GPRE) is North America's fourth largest ethanol producer, operating a total of six ethanol plants in Indiana, Iowa, Nebraska and Tennessee with annual expected operating capacity totaling approximately 500 million gallons. Green Plains also markets and distributes ethanol for four third-party ethanol producers with annual expected operating capacity totaling approximately 360 million gallons. Green Plains owns 51% of Blendstar, LLC, a biofuel terminal operator which operates nine blending or terminaling facilities with approximately 495 million gallons per year of total throughput capacity in seven states in the south central United States. Green Plains operates grain storage facilities and complementary agronomy and petroleum businesses in Iowa, southern Minnesota and western Tennessee.

-------------------------------------------

Vertex Pharmaceuticals Incorporated closed at $33.19 Wednesday, trading 718,700 shares.

Vertex Pharmaceuticals Reports Second Quarter 2010 Financial Results and Highlights Recent Business and Clinical Progress

CAMBRIDGE, Mass., July 28, 2010 -- Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) today provided an update on recent progress in its development programs in hepatitis C virus (HCV) infection, cystic fibrosis (CF) and other diseases and reported consolidated financial results for the quarter ended June 30, 2010.

About Vertex

Vertex Pharmaceuticals Incorporated is a global biotechnology company committed to the discovery and development of breakthrough small molecule drugs for serious diseases. The Company's strategy is to commercialize its products both independently and in collaboration with major pharmaceutical companies. Vertex's product pipeline is focused on viral diseases, cystic fibrosis, inflammation, autoimmune diseases, epilepsy, cancer, and pain.

-------------------------------------------

About StockProfiler.US

StockProfiler.US is a media source for publicly traded small cap companies and investors to come together and discover market opportunities. Public companies can effectively broadcast their message to a targeted audience who come to StockProfiler.US seeking an advantage by discovering companies in their startup phase or ones who have yet to be discovered by the investment community.

-----------------------------------------

Please Note: All news contained herein has been previously issued by the companies mentioned in this release, and is the property of each company, respectively. All news is edited for content. The companies that are discussed in this opinion have not approved the statements made in this opinion.

This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities.

Stock Profiler.US, LLC's News Division includes but is not limited to: http://www.stockprofiler.us, http://www.associatesfortune.com, http://www.fastmoneytalk.com, http://www.markettelegraph.com, http://www.thewallstreetleader.com, and http://www.daytradersdigest.com.

Stock Profiler.US, LLC has been compensated for services rendered; Stock Profiler.US, LLC is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter.

To view full disclaimers and terms of use, go to http://stockprofiler.us/Disclaimer.

-------------------------------------------

Keywords: nasdaq stock, nasdaq stock news, nasdaq stock alerts, nasdaq stock updates, nasdaq stock news updates, nasdaq stock profile

((M2 Communications disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info@m2.com.

For full details on (AEGC) AEGC. (AEGC) has Short Term PowerRatings at TradingMarkets. Details on (AEGC) Short Term PowerRatings is available at This Link.

For full details on Green Plains Renewable Energy (GPRE) GPRE. Green Plains Renewable Energy (GPRE) has Short Term PowerRatings at TradingMarkets. Details on Green Plains Renewable Energy (GPRE) Short Term PowerRatings is available at This Link.

How to Successfully Trade ETFs

Do you want to learn how to trade more successfully, more consistently... and with more confidence?

If so, then the TPS strategy is for you.

Hundreds, if not now thousands, of ETF traders successfully use the TPS trading strategy to find the best ETF trade set-ups each day to place winning trades.

What stocks and ETFs are headed up and down this week?.

The TradingMarkets Weekly Newsletter covers this in depth and gives performance information on the previous week.

UPCOMING EVENTS

Learn new strategies, how to trade in this market, and the stocks you should be focusing on each day. Join us for our free 20 minute tele-seminars during the week.

Thursday September 16 12:30 PM

Hear What Kevin Haggerty Sees in the Stock Market Today!

Wednesday September 15 01:30 PM

Building High Performing Portfolios with The Machine

* Attendance is strictly limited and are filled on a first-come, first-served basis.

1.	How I Trade: 5 Traders Discuss Their Overall Trading Strategies
2.	4 Mental Keys That Help My Trading Performance
3.	How to Trade Shakeouts
4.	3 Ways to Maximize Your Returns
5.	5 Ways to Handle The Quicksand Of Trading
6.	Buying Weakness and Selling Strength
7.	Looking Beyond Indicators
8.	10 Steps to Successful Day Trading, Part 1
9.	How to Gain Confidence, Commitment, Courage, and Control
10.	2 Indicators to Help You Find Market Bottoms

Name	Symbol	PR
SPDR Barclays Capital Municipal Bond ETF	TFI	10
Expressjet Holdings Inc	XJT	10
SPDR Lehman International Treasury Bond ETF	BWX	9
ProShares Trust II: UltraShort DJ-AIG Commodity	CMD	9
iShares JPMorgan USD Emerging Markets Bond Fund	EMB	9
ProShares UltraShort MSCI Pacific ex-Japan	JPX	9
PowerShares Emerging Markets Sovereign Debt Portfolio	PCY	9
SPDR Barclays Capital Short Term Municipal Bond ETF	SHM	9
Americredit Corp	ACF	8
Arc Sight, Inc.	ARST	8

About TradingMarkets Advertise Contact Careers Link to Us Help Terms & Conditions Privacy Policy Return Policy Testimonials Feedback

Disclaimer:

The Connors Group, Inc. ("Company") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities or currencies customers should buy or sell for themselves. The analysts and employees or affiliates of Company may hold positions in the stocks, currencies or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities and/or currencies. The Company, the authors, the publisher, and all affiliates of Company assume no responsibility or liability for your trading and investment results. Factual statements on the Company's website, or in its publications, are made as of the date stated and are subject to change without notice.

It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by Company are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of Company's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on Company's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.

HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN INHERENT LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING AND MAY NOT BE IMPACTED BY BROKERAGE AND OTHER SLIPPAGE FEES. ALSO, SINCE THE TRADES HAVE NOT ACTUALLY BEEN EXECUTED, THE RESULTS MAY HAVE UNDER- OR OVER-COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFITS OR LOSSES SIMILAR TO THOSE SHOWN.

The Connors Group, Inc.
10 Exchange Place, Suite 1800
Jersey City, NJ 07302

All analyst commentary provided on TradingMarkets.com is provided for educational purposes only. The analysts and employees or affiliates of TradingMarkets.com may hold positions in the stocks or industries discussed here. This information is NOT a recommendation or solicitation to buy or sell any securities. Your use of this and all information contained on TradingMarkets.com is governed by the Terms and Conditions of Use. Please click the link to view those terms. Follow this link to read our Editorial Policy.